Literature DB >> 12203732

Perlecan participates in proliferation activation of quiescent Drosophila neuroblasts.

Aaron Voigt1, Ralf Pflanz, Ulrich Schäfer, Herbert Jäckle.   

Abstract

Drosophila neuroblasts act as stem cells. Their proliferation is controlled through cell cycle arrest and activation in a spatiotemporal pattern. Several genes have been identified that control the pattern of neuroblast quiescence and proliferation in the central nervous system (CNS), including anachronism (ana), even skipped (eve) and terribly reduced optic lobes (trol). eve acts in a non-cell-autonomous manner to produce a transacting factor in the larval body that stimulates cell division in the population of quiescent optic lobe neuroblasts. ana encodes a secreted glial glycoprotein proposed to repress premature proliferation of optic lobe and thoracic neuroblasts. trol was shown to act downstream of ana to activate proliferation of quiescent neuroblasts either by inactivating or bypassing ana-dependent repression. Here, we show that trol codes for Drosophila Perlecan, a large multidomain heparan sulfate proteoglycan originally identified in extracellular matrix structures of mammals. The results suggest that trol acts in the extracellular matrix and binds, stores, and sequesters external signals and, thereby, participates in the stage- and region-specific control of neuroblast proliferation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203732     DOI: 10.1002/dvdy.10120

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  55 in total

1.  Shaping cells and organs in Drosophila by opposing roles of fat body-secreted Collagen IV and perlecan.

Authors:  José Carlos Pastor-Pareja; Tian Xu
Journal:  Dev Cell       Date:  2011-08-16       Impact factor: 12.270

2.  Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization.

Authors:  Martina Schneider; Ashraf A Khalil; John Poulton; Casimiro Castillejo-Lopez; Diane Egger-Adam; Andreas Wodarz; Wu-Min Deng; Stefan Baumgartner
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

Review 3.  Cell-cell communication and axis specification in the Drosophila oocyte.

Authors:  John S Poulton; Wu-Min Deng
Journal:  Dev Biol       Date:  2007-08-22       Impact factor: 3.582

Review 4.  Shaping morphogen gradients by proteoglycans.

Authors:  Dong Yan; Xinhua Lin
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

5.  A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.

Authors:  Mary C Farach-Carson; Anissa J Brown; Megan Lynam; Jeffrey B Safran; Daniel D Carson
Journal:  Matrix Biol       Date:  2007-10-10       Impact factor: 11.583

6.  Systematic gene targeting on the X chromosome of Drosophila melanogaster.

Authors:  Nicole Beinert; Meike Werner; Gordon Dowe; Ho-Ryun Chung; Herbert Jäckle; Ulrich Schäfer
Journal:  Chromosoma       Date:  2004-10-12       Impact factor: 4.316

7.  Perlecan is required for FGF-2 signaling in the neural stem cell niche.

Authors:  Aurelien Kerever; Frederic Mercier; Risa Nonaka; Susana de Vega; Yuka Oda; Bernard Zalc; Yohei Okada; Nobutaka Hattori; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Stem Cell Res       Date:  2013-12-28       Impact factor: 2.020

8.  Genetic mapping of male pheromone response in the European corn borer identifies candidate genes regulating neurogenesis.

Authors:  Fotini A Koutroumpa; Astrid T Groot; Teun Dekker; David G Heckel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

Review 9.  Building from the Ground up: Basement Membranes in Drosophila Development.

Authors:  Adam J Isabella; Sally Horne-Badovinac
Journal:  Curr Top Membr       Date:  2015-07-30       Impact factor: 3.049

Review 10.  Diverse cell signaling events modulated by perlecan.

Authors:  John M Whitelock; James Melrose; Renato V Iozzo
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.